The study of human physiology and disease is deeply enhanced by immortalised cell lines. These systems allow scientists to focus on specific organ functions, disease processes, and therapeutic responses without the ethical and practical challenges of direct experimentation on humans. By providing reproducible and adaptable models, cell lines serve as gateways into complex biological systems, making them indispensable in both fundamental and translational research.
The following sections examine ten of the most important cell lines, each representing a unique dimension of physiology and pathology.
HeLa Cells and the Dynamics of Cancer Growth
The introduction of HeLa cells in 1951 provided a unique opportunity to study uncontrolled cell division, a defining feature of cancer. These cervical carcinoma-derived cells rapidly became the foundation of tumour biology research, offering clues about how malignant cells escape regulatory signals.
HeLa has provided insights into:
- Cell cycle regulation, highlighting how mutations alter checkpoints and lead to unchecked proliferation.
- Chromosomal abnormalities, including polyploidy and structural instability, which characterise many cancers.
- Virus–cancer relationships, particularly through studies on human papillomavirus (HPV).
Their immortal nature, while scientifically invaluable, also underscores the challenges of relying solely on cancer-derived lines, as their genomic instability makes them less representative of healthy cells. Still, they remain the most famous example of how a single patient’s tumour became a permanent lens for exploring cancer biology.
HEK293 and Cellular Communication Pathways
HEK293 cells, though originally derived from embryonic kidney tissue, are most widely recognised for their role in studying how cells communicate through proteins and receptors. Their capacity for high-efficiency transfection means they can be engineered to express receptors from various human tissues.
They are central to investigations of:
- Signal transduction, particularly G-protein coupled receptors and ion channels.
- Genetic modification techniques, where HEK293 cells act as hosts for CRISPR-Cas9 experiments.
- Pharmaceutical design, through receptor-ligand binding studies.
In this way, HEK293 provides a “blank canvas” for scientists to explore molecular signalling pathways, enabling discoveries that extend across physiology, neuroscience, and pharmacology.
CHO Cells and Protein Processing
While derived from a rodent source, CHO cells highlight the importance of protein folding and processing in mammalian systems. Their ability to produce human-compatible post-translational modifications makes them indispensable for biotechnological production of biologics.
CHO cells illuminate aspects of physiology such as:
- Glycosylation, which influences immune recognition, hormone function, and protein stability.
- Secretion pathways, reflecting how cells export proteins into circulation.
- Adaptation to stress, as CHO cells can be optimised to survive under industrial culture conditions.
By functioning as a surrogate for human protein processing, CHO cells bridge basic cellular mechanisms with large-scale therapeutic development.
SH-SY5Y and Neuronal Differentiation
The SH-SY5Y neuroblastoma line offers a remarkable tool for understanding how neurons develop and function. Under appropriate conditions, they differentiate into neuron-like cells, producing neurotransmitters and extending neurites.
They shed light on neurological physiology and pathology, including:
- Synaptic transmission, revealing how neurotransmitters are released and recycled.
- Neurodegeneration, with models for oxidative stress, mitochondrial dysfunction, and protein aggregation.
- Developmental plasticity, as they can mimic features of both immature and mature neurons.
For researchers tackling conditions such as Parkinson’s or Alzheimer’s disease, SH-SY5Y serves as a scalable and reproducible neuronal proxy.
MCF7 and the Endocrine Axis of Breast Cancer
The MCF7 breast cancer line underscores the interplay between endocrine signalling and tumour growth. These cells retain oestrogen receptor activity, making them particularly suitable for studying hormone-dependent cancers.
MCF7 cells illuminate:
- Endocrine physiology, demonstrating how oestrogen drives cellular proliferation.
- Drug resistance, highlighting adaptive pathways when endocrine therapies fail.
- Apoptosis regulation, informing strategies to trigger programmed cell death in tumour cells.
This line represents a precise gateway into the hormonal influences that shape tumour behaviour, reinforcing the importance of the endocrine system in pathology.
THP1 and Immune System Responses
THP1 cells, derived from monocytic leukaemia, provide a reproducible platform for investigating innate immune responses. With differentiation, they mimic macrophage-like cells capable of phagocytosis and cytokine production.
They are instrumental in understanding:
- Inflammatory pathways, especially Toll-like receptor signalling.
- Pathogen recognition, modelling how the immune system responds to bacterial and viral infections.
- Immunotoxicity, where drug candidates are tested for unintended suppression or overstimulation of immune function.
By serving as a surrogate for human monocytes, THP1 cells allow researchers to dissect the intricacies of immune physiology in both health and disease.
A2780 and Mechanisms of Ovarian Cancer Resistance
The ovarian carcinoma line A2780 represents a model for understanding how tumours adapt to chemotherapy. Their sensitivity to platinum-based drugs has made them invaluable for exploring DNA damage and repair mechanisms.
They provide insights into:
- DNA repair physiology, by highlighting pathways that allow cells to recover from cisplatin-induced lesions.
- Cell survival signalling, where resistant sublines reveal adaptation strategies.
- Combination therapies, offering opportunities to evaluate synergistic effects of drugs.
Through A2780 studies, researchers gain a clearer picture of why some cancers respond initially to therapy but relapse due to acquired resistance.
HL-60 and the Differentiation of Blood Cells
HL-60 cells, established from acute promyelocytic leukaemia, are among the best tools for studying haematopoietic differentiation. These cells can transform into granulocytic or monocytic forms depending on treatment.
They reveal critical aspects of:
- Blood cell physiology, particularly how immature precursors mature into functional immune cells.
- Differentiation therapies, such as retinoic acid treatment in leukaemia.
- Cytotoxic testing, offering insight into how environmental agents or drugs impact blood-forming tissues.
As a model of both normal and malignant haematopoiesis, HL-60 remains indispensable for linking differentiation biology with therapeutic development.
Caco-2 and Nutrient Absorption
The Caco-2 colon carcinoma line is widely used to model the intestinal epithelium. When cultured, these cells form tight junctions and develop brush-border membranes similar to small intestine enterocytes.
They provide clarity on:
- Nutrient absorption, simulating how the gut takes up vitamins, minerals, and amino acids.
- Drug transport, particularly permeability and efflux mechanisms that influence oral bioavailability.
- Barrier integrity, helping to model gastrointestinal diseases where epithelial tight junctions are compromised.
Caco-2 experiments are often required during pharmaceutical development, demonstrating their vital role in bridging gastrointestinal physiology with drug evaluation.
HepG2 and Liver Function Studies
Derived from hepatocellular carcinoma, HepG2 cells are a cornerstone for investigating hepatic function. Though less metabolically complete than primary hepatocytes, their stability and availability make them central to toxicological and metabolic studies.
They have been used to understand:
- Detoxification pathways, including phase II metabolism of drugs and toxins.
- Lipid metabolism, with applications in studying fatty liver disease.
- Viral hepatology, as a platform for hepatitis virus research.
HepG2 cells provide a practical means of exploring the liver’s complex physiology, particularly in contexts where primary tissue is unavailable.
Conclusion
Immortalised cell lines provide powerful gateways into specific aspects of human physiology and pathology. HeLa opened the door to tumour biology, HEK293 revealed gene function and signalling, and CHO advanced protein production. SH-SY5Y enabled neuronal modelling, while MCF7 illuminated endocrine-driven cancers. THP1 unravelled immune signalling, A2780 clarified drug resistance, HL-60 demonstrated haematopoietic differentiation, Caco-2 simulated the intestinal barrier, and HepG2 provided insight into liver metabolism.
Although no model can perfectly replicate the complexity of human tissues, together these lines offer a mosaic of perspectives that continues to advance medicine. They remain indispensable for bridging laboratory findings with clinical understanding, ensuring that insights gained at the cellular level inform both diagnostics and therapeutics.